Ronald T Haas

Title: The Innovations of Ronald T. Haas in Pharmaceutical Formulations

Introduction

Ronald T. Haas is an accomplished inventor based in Highland Ranch, Colorado, known for his contributions to the pharmaceutical industry. He holds a patent for a unique formulation that provides a constant release rate of indomethacin, showcasing his innovative spirit and expertise in drug formulation.

Latest Patents

Haas's notable patent is titled "Constant order release, solid dosage indomethacin formulation and method." This innovative formulation is designed in tablet unit dosage form and includes a carefully crafted mixture of ingredients. It features from 50 to 200 mg of indomethacin, 1.7 to 3.7 weight percent of a slow-dissolving, water-insoluble cellulose derivative, 1.5 to 5.0 weight percent of a tabletting disintegrant, and 40 to 80 weight percent of a pharmaceutically acceptable bulking agent or diluent. This formulation aims to improve drug delivery and patient compliance, demonstrating Haas's commitment to enhancing pharmaceutical solutions.

Career Highlights

Ronald T. Haas is currently employed by Verex Laboratories, Inc., where he applies his knowledge and skills to the development of innovative pharmaceutical products. His work at Verex is marked by a focus on creating formulations that enhance the efficacy and safety of medications, contributing significantly to the company's mission of advancing healthcare through innovation.

Collaborations

During his career, Haas has collaborated with colleagues like James M. Dunn, leveraging their collective expertise to drive forward the development of cutting-edge drug formulations. These collaborations have been instrumental in refining his inventions and ensuring they meet the highest standards of pharmaceutical excellence.

Conclusion

With a patent to his name and a position at Verex Laboratories, Inc., Ronald T. Haas exemplifies the spirit of innovation in the pharmaceutical industry. His work on the constant release indomethacin formulation not only highlights his inventiveness but also underscores the importance of continuous improvement in drug delivery systems. Haas's contributions are a valuable asset to the field, paving the way for advancements that benefit both healthcare providers and patients alike.